Original paper
Association between immune-related adverse events and clinical outcomes to PD-1/PD-L1 blockade in small cell lung cancer
Abstract
Background null The development of immune-related adverse events (irAEs) has been associated with improved efficacy of immune checkpoint inhibitors in patients with urothelial cancer, melanoma, and non-small cell lung cancer. Whether this association exists in patients with small cell lung cancer (SCLC) is currently unknown. null null null Methods null We conducted a multicenter retrospective study to evaluate the relationship between irAEs and...
Paper Details
Title
Association between immune-related adverse events and clinical outcomes to PD-1/PD-L1 blockade in small cell lung cancer
Published Date
Aug 1, 2020
Pages
100092 - 100092
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History